Marketing Department of IMI FARMA Ltd is one of the first medical promotion departments in Albania, established in 1997. During 20 years of its operation, is transmitting to the Albanian doctors the newest information and the most valuable for them in every clinical field, respecting the ethic code of medical promotion. This information has been transmitted through face to face calls and activities held in Albania by different medical associations, providing a comprehensive support. This department has participated in almost all national conferences of the Association of Neurology, Cardiology, Psychiatry, Internal Medicine, Anesthesia-Intensive Care, Gynecology, Endocrinology, Alergology etc. The marketing department has organized as well, meetings and activities with general practitioners and specialists in order to provide them the information resources and to receive from their experience, the feedback of the promoted products, some of which presented in the international market in the recent years. Marketing Department of IMI FARMA Ltd has established a collaboration with Health Authorities. As a result of this collaboration is made possible reimbursement of some important drugs in the treatment of various diseases such as: diabetes, myocardial infarction, epilepsy, etc. In collaboration, we are providing supply of the hospitals with a variety of medications needed to treat patients with diseases such as: breast cancer, prostate, pulmonary embolism, etc.
The Marketing Department of IMIFARMA ltd performs at the National Agency of Drugs and Medical Devices the procedures for: Marketing Authorization, Renewals and Variations, for the below mentioned companies:
MERCK / GERMANY
Among the products that are promoted by the Marketing Department of IMI FARMA Ltd we may include the products of Merck Company
Founded in 1668, Merck, Darmstadt Germany, is the world's oldest pharmaceutical and chemical company. It is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, gynecology, endocrinology and rheumatology.
Over 5,000 Merck researchers are dedicated to discovering pioneering health solutions and developing new technologies. In 2015, their researches and development has spent a total of € 1.7 billion.
IMIFARMA has the exclusivity of a number of medicines produced by Merck Company:
REBIF 22mcg/44mcg (Interferon beta-1a)
SAIZEN 8mg Click Easy (Somatropin for injection)
GONAL-F 75IU (folliotropin alfa)
GONAL F 450IU (folliotropin alfa)
PERGOVERIS (folliotropin alfa + leutropin alfa)
CRINON 8% vaginal gel (progesterone)
GLUCOPHAGE 500mg/ 850mg/ 1000mg (metphormin)
EUTHYROX 25mcg/ 50mcg/ 100mcg (levothyroxine)
CONCOR 0.25mg/5mg/10mg (bisoprolol)
OVITRELLE 250mcg/0.5ml(choriogonadotropin alfa)
CETROTIDE 0.25mg (cetrorelix ( as acetate))
2 dekada Eksperience ne distribucion bejne qe IMIFARMA te mbuloje te gjithe territorin shqiptarMe shume
IMIFARMA zoteron tre linja prodhimi dhe prodhon barna humane, veterinare dhe suplemente....Me shume
IMI FARMA eshte e vertifikuar per shperndarjen e produkteve Yves Rocher ne ShqiperiMe shume
IMI FARMA e pajisur me teknologjine me te fundit farmaceutike per prodhimin e barnave veterinareMe shume